Biocatalytic synthesis of enantiopure building blocks for pharmaceuticals

Drug Discovery Today: Technologies

Volumn 10, Issue 1, 2013, Pages

  Simon, Robert C ^a   Mutti, Francesco G ^b   Kroutil, Wolfgang ^b  

^a AUSTRIAN CENTRE OF INDUSTRIAL BIOTECHNOLOGY   (Austria)

^b Institute of Chemistry   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

13 DEOXYTEDANOLIDE DICTYOSTATIN; ALCOHOL DEHYDROGENASE; AMINOTRANSFERASE; ANTIBIOTIC AGENT; ATORVASTATIN; BAEYER VILLIGER MONOOXYGENASE; BERBERINE; CALCIMYCIN; CYANOHYDRIN; CYTOTOXIN; DIOXYGENASE; DULOXETINE; FLUOXETINE; FLURBIPROFEN; FRUCTOSE BISPHOSPHATE ALDOLASE; HYDROXYNITRILE LYASE; HYPERICUM EXTRACT; HYPERIONE A; HYPERIONE B; IRCINIASTATIN A; LIPASE B; MONTELUKAST; OSELTAMIVIR; OXIDOREDUCTASE; PALINURIN; RAPAMYCIN; RIVASTIGMINE; SULOPENEM; UNCLASSIFIED DRUG; UNINDEXED DRUG; UNSPECIFIC MONOOXYGENASE;

ALMOND; BIOCATALYSIS; DRUG SYNTHESIS; DRUG TRANSFORMATION; ENANTIOMER; ENANTIOSELECTIVITY; ENZYME KINETICS; HEVEA BRASILIENSIS; HUMAN; NONHUMAN; REVIEW; STEREOCHEMISTRY;

ANIMALS; BIOCATALYSIS; HYDROLASES; LYASES; OXIDOREDUCTASES; PHARMACEUTICAL PREPARATIONS; STEREOISOMERISM; TRANSAMINASES;

EID: 84875701703     PISSN: None     EISSN: 17406749     Source Type: Journal    
DOI: 10.1016/j.ddtec.2012.08.002     Document Type: Review

References (40)

1. R.N. Patel Biocatalysis: synthesis of key intermediates for development of pharmaceuticals ACS Catal. 1 2011 1056 1074
2. S. Sanchez, and A.L. Demain Enzymes and bioconversions of industrial, pharmaceutical and biotechnological significance Org. Process Res. Dev. 1 2011 224 230
3. M. Mahmoudian Biocatalysis: the road ahead Org. Process Res. Dev. 15 2011 173 174
4. N.J. Turner Deracemisation methods Curr. Opin. Chem. Biol. 14 2010 115 121
5. R.M. Schmaltz Enzymes in the synthesis of glycoconjugates Chem. Rev. 111 2011 4259 4307
6. E. Busto Hydrolases: catalytically promiscuous enzymes for non-conventional reactions in organic synthesis Chem. Soc. Rev. 39 2011 4504 4523
7. T. Fischer, and J. Pietruszka Key building blocks via enzyme-mediated synthesis Top. Curr. Chem. 297 2010 1 43
8. J. Pietruszka, and R.C. Simon Chemoenzymatic synthesis of (protected) psymberic acid Eur. J. Org. Chem. 2009 2009 3628 3634
9. A. Träff A chemoenzymatic dynamic kinetic resolution approach to enantiomerically pure (R)- and (S)-duloxetine J. Org. Chem. 76 2011 3917 3921
10. K. Han Chemoenzymatic synthesis of rivastigmine via dynamic kinetic resolution as a key step J. Org. Chem. 75 2010 3105 3108
11. A. Rioz-Martinez Dynamic kinetic resolution of α-substituted β-ketoesters catalyzed by Baeyer-Villiger monooxygenases: access to enantiopure α-hydroxy esters Angew. Chem. Int. Ed. 50 2011 8387 8390
12. C.M. Sapu Enantioselective enzymatic desymmetrization of prochiral allenic diols Angew. Chem. Int. Ed. 50 2011 9734 9737
13. J. Holt, and U. Hanefeld Enantioselective enzyme-catalysed synthesis of cyanohydrins Curr. Org. Synth. 6 2009 15 37
14. B. Ritzen Enantioselective chemoenzymatic synthesis of cis- and trans-2,5-disubstituted morpholines J. Org. Chem. 75 2010 3461 3464
15. D.G. Gillingham Chemoenzymatic synthesis of differentially protected 3-deoxysugars Nat. Chem. 2 2010 102 105
16. F. Hollmann Enzymatic reductions for the chemist Green Chem. 11 2011 2285 2313
17. J.H. Schrittwieser Recent biocatalytic oxidation-reduction cascades Curr. Opin. Chem. Biol. 15 2011 249 256
18. L. Werner Serveral generations of chemoenzymatic synthesis of oseltamivir (Tamiflu): evolution of strategy, quest for a process-quality synthesis, and evaluation of efficiency metrics J. Org. Chem. 76 2011 10050 10067
19. S.M.A. de Wildeman Biocatalytic reductions: from lab curiosity to 'first choice' Acc. Chem. Res. 40 2007 1260 1266
20. S.K. Ma A green-by-design biocatalytic process for atorvastatin intermediate Green Chem. 12 2010 81 86
21. L-J. Wang Highly efficient synthesis of chiral alcohols with a novel NADH-dependent reductase from Streptomyces coelicolor Bioresour. Technol. 102 2011 7023 70287
22. M. Badland Application of biocatalysis towards asymmetric reduction and hydrolytic desymmetrisation in the synthesis of a β-3 receptor agonist Green Chem. 13 2011 2888 2894
23. J. Liang Highly enantioselective reduction of a small heterocyclic ketone: biocatalytic reduction of tetrahydrothiophene-3-one to the corresponding (R)-alcohol Org. Process Res. Dev. 14 2010 188 192
24. J. Liang Development of a biocatalytic process as an alternative to the (-)-DIP-Cl-mediated asymmetric reduction of a key intermediate of montelukast Org. Process Res. Dev. 14 2010 193 198
25. N.A. Magnus Diarylketone ketoreductase screen and synthesis demonstration to access mGlu2 receptor potentiators Org. Process Res. Dev. 15 2011 1377 1381
26. G.A. Applegate A new dehydrogenase from Clostridium acetobutylicum for asymmetric synthesis: dynamic reductive kinetic resolution entry into the taxotère side chain Chem. Commun. 47 2011 2420 2422
27. C. Stueckler Asymmetric synthesis of (R)-3-hydroxy-2-methylpropanoate ('Roche ester') and derivatives via biocatalytic CC-bond reduction Adv. Synth. Catal. 352 2010 2663 2666
28. M. Schölzel, and J. Pietruszka Ene reductase-catalysed synthesis of (R)-profen derivatives Adv. Synth. Catal. 354 2012 751 756
29. E. Brenna Productivity enhancement of CC bioreductions by coupling the in situ substrate feeding product removal technology with isolated enzymes Chem. Commun. 48 2012 79 81
30. A. Znabet A highly efficient synthesis of telaprevir by strategic use of biocatalysis and multicomponent reactions Chem. Commun. 46 2010 7918 7920
31. A. Znabet Highly stereoselective synthesis of substituted prolyl peptides using a combination of biocatalytic desymmetrization and multicomponent reactions Angew. Chem. Int. Ed. 49 2010 5289 5292
32. D. Koszelewski ω-Transaminases for the synthesis of non-racemic α-chiral primary amines Trends Biotechnol. 28 2010 324 332
33. C.K. Savile Biocatalytic asymmetric synthesis of chiral amines from ketones applied to sitagliptin manufacture Science 329 2010 305 309
34. M.D. Truppo Efficient production of enantiomerically pure chiral amines at concentrations of 50 g/L using transaminases Org. Process Res. Dev. 14 2010 234 237
35. M. Fuchs Chemoenzymatic asymmetric total synthesis of (S)-rivastigmine using ω-transaminases Chem. Commun. 46 2010 5500 5502
36. F.G. Mutti Stereoselectivity of four (R)-selective transaminases for the asymmetric amination of ketones Adv. Synth. Catal. 353 2011 3227 3233
37. M. Höhne Rational assignment of key motifs for function guides in silico enzyme identification Nat. Chem. Biol. 6 2010 807 813
38. M.E.B. Smith A multidisciplinary approach toward the rapid and preparative-scale biocatalytic synthesis of chiral amino alcohols: a concise transketolase-/ω-transaminase-mediated synthesis of (2S,3S)-2- aminopentane-1,3-diol Org. Process Res. Dev. 14 2010 99 107
39. J.H. Schrittwieser Biocatalytic enantioselective oxidative CC coupling by aerobic CH activation Angew. Chem. Int. Ed. 50 2011 1068 1071
40. J.H. Schrittwieser Biocatalytic organic synthesis of optically pure (S)-scoulerine and berbine and benzylisoquinoline alkaloids J. Org. Chem. 76 2011 6703 6714